LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $477,894 | +15.4% | 318,596 | -10.0% | 0.02% | -21.1% |
Q4 2022 | $414,169 | +11.0% | 353,991 | +7.3% | 0.02% | +58.3% |
Q3 2022 | $373,000 | -24.0% | 329,826 | +8.2% | 0.01% | -14.3% |
Q2 2022 | $491,000 | +69.9% | 304,934 | +58.3% | 0.01% | +133.3% |
Q1 2022 | $289,000 | -44.3% | 192,627 | -7.3% | 0.01% | -40.0% |
Q4 2021 | $519,000 | – | 207,735 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,005,379 | $85,694,000 | 4.37% |
Defender Capital, LLC. | 4,798,270 | $12,707,000 | 4.13% |
Raffles Associates | 93,590 | $236,000 | 0.22% |
Prescott General Partners LLC | 1,851,851 | $4,667,000 | 0.16% |
DCF Advisers, LLC | 87,000 | $219,000 | 0.10% |
Laidlaw Wealth Management LLC | 104,841 | $264,000 | 0.07% |
Beirne Wealth Consulting Services, LLC | 45,000 | $113,000 | 0.06% |
Strategic Wealth Investment Group, LLC | 70,625 | $179,000 | 0.05% |
Fort Sheridan Advisors LLC | 47,931 | $121,000 | 0.04% |
Sightline Wealth Advisors, LLC | 14,958 | $38,000 | 0.03% |